OTCMKTS:PVOTFPivot Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Pivot Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.60 -0.15 (-8.57 %) (As of 07/3/2020 04:00 PM ET) Add Compare Share Today's Range$1.39Now: $1.60▼$1.7550-Day Range$0.11MA: $0.22▼$1.4652-Week Range$0.03Now: $1.60▼$0.38Volume40,344 shsAverage VolumeN/AMarket Capitalization$274.26 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media Pivot Pharmaceuticals, Inc. is a development stage biopharmaceutical company. It is engaged in the development and commercialization of therapeutic pharmaceutical products, with a strategic emphasis on the innovation of new therapeutic uses for existing drugs. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Pivot Pharmaceuticals. Previous Next 2.6 Community Rank Outperform VotesPivot Pharmaceuticals has received 56 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPivot Pharmaceuticals has received 51 “underperform” votes. (Add your “underperform” vote.)Community SentimentPivot Pharmaceuticals has received 52.34% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Pivot Pharmaceuticals and other stocks. Vote “Outperform” if you believe PVOTF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PVOTF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPivot Pharmaceuticals does not currently pay a dividend.Dividend GrowthPivot Pharmaceuticals does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pivot Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 34.77% of the stock of Pivot Pharmaceuticals is held by insiders. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Pivot Pharmaceuticals is -14.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Pivot Pharmaceuticals is -14.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPivot Pharmaceuticals has a P/B Ratio of 160.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PVOTF Previous Symbol CUSIPN/A CIK1464165 Webpivotpharma.com Phone604-805-7783Debt Debt-to-Equity RatioN/A Current Ratio3.62 Quick Ratio3.62Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book160.00Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-14,780,000.00 Net MarginsN/A Return on Equity-205.15% Return on Assets-147.23%Miscellaneous EmployeesN/A Outstanding Shares171,410,000Market Cap$274.26 million Next Earnings DateN/A OptionableNot Optionable OTC:PVOTF Rates by TradingView Receive PVOTF News and Ratings via Email Sign-up to receive the latest news and ratings for PVOTF and its competitors with MarketBeat's FREE daily newsletter. Pivot Pharmaceuticals (OTCMKTS:PVOTF) Frequently Asked Questions How has Pivot Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)? Pivot Pharmaceuticals' stock was trading at $0.0714 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PVOTF shares have increased by 2,140.9% and is now trading at $1.60. View which stocks have been most impacted by Coronavirus. How were Pivot Pharmaceuticals' earnings last quarter? Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) released its earnings results on Monday, June, 1st. The company reported ($0.05) earnings per share (EPS) for the quarter. View Pivot Pharmaceuticals' earnings history. Has Pivot Pharmaceuticals been receiving favorable news coverage? News articles about PVOTF stock have been trending negative recently, InfoTrie reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Pivot Pharmaceuticals earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the near term. View the latest news about Pivot Pharmaceuticals. Who are some of Pivot Pharmaceuticals' key competitors? Some companies that are related to Pivot Pharmaceuticals include DiaMedica Therapeutics (DMCAF), Athenex (ATNX), Arcus Biosciences (RCUS), Aimmune Therapeutics (AIMT), Phibro Animal Health (PAHC), BioXcel Therapeutics (BTAI), Amphastar Pharmaceuticals (AMPH), Legend Biotech (PLRX), Enanta Pharmaceuticals (ENTA), Rhythm Pharmaceuticals (RYTM), Nabriva Therapeutics (NBRV), Akero Therapeutics (AKRO), Arcturus Therapeutics (ARCT), Phathom Pharmaceuticals (PHAT) and Retrophin (RTRX). View all competitors. Who are Pivot Pharmaceuticals' key executives? Pivot Pharmaceuticals' management team includes the following people: Joseph Borovsky, Chairman & Executive Vice President-TechnologyPatrick Charles Frankham, President, CEO, Director & VP-Business DevelopmentMoira Ong, Chief Financial OfficerWolfgang Renz, Director & Chief Medical Officer What is Pivot Pharmaceuticals' stock symbol? Pivot Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PVOTF." How do I buy shares of Pivot Pharmaceuticals? Shares of PVOTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Pivot Pharmaceuticals' stock price today? One share of PVOTF stock can currently be purchased for approximately $1.60. How big of a company is Pivot Pharmaceuticals? Pivot Pharmaceuticals has a market capitalization of $274.26 million. What is Pivot Pharmaceuticals' official website? The official website for Pivot Pharmaceuticals is pivotpharma.com. How can I contact Pivot Pharmaceuticals? Pivot Pharmaceuticals' mailing address is 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6. The company can be reached via phone at 604-805-7783. This page was last updated on 7/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
